Free Newsletter
GSK accused of distorting antidepressant data
Free newsletter via e-mail
Tools
The BBC says it will air a program tonight that claims GlaxoSmithKline distorted trial data in an attempt to gain regulators' approval to use the antidepressant Seroxat as a therapy for children. The report claims that Glaxo covered up the drug's link to teen suicide and hid the fact that the drug had failed clinical trials. Glaxo, though, flatly rejected the report's conclusion, saying it never hid any data and brought the information to the attention of regulators.
- check out the press release from the BBC
- read GSK's statement on the accusations
- read the BBC's online report
ALSO: European regulators have agreed to review Glaxo's pre-pandemic flu vaccine. Report
Related Articles:
Study highlights link between Paxil and suicide. Report
GSK prepares to go head-to-head with Merck. Report
Glaxo forges $2.1B deal for HuMax-CD20. Report
GSK sees success with RLS campaign. Report
More stories about Vaccines Regulators pandemic flu Merck HuMax CD-20 GlaxoSmithKline flu vaccine antidepressant
Comments
By smjacob | Posted 6:53pm | August 5, 2007
GSK has no excuse for tampering with the antidepressants data. The company can deny all they like, but that doesn't change the fact that all the evidences and suspicions lead to their guild. Maybe the jury will not find them guilty, but the public will surely suspect something with this company, and that will show on their sales. Credibility in the pharmaceutical business is the most important thing (that's why the companies selling online medications took off so hard).
